|Articles|June 28, 2023

DIA 2023: PALADIN Brings Patient Advocacy and Industry Together

New pre-competitive, disease-agnostic Consortium hopes to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.

In this interview, Vicky DiBiaso, Global Head, Patient Informed Development & Health Value Translation at Sanofi and Kenneth Getz, Executive Director/Professor, Tufts CSDD and Founder/Board Chair, CISCRP, discuss the formation, mission and goals for the newly-launched Patient Advocacy Leaders And Drug (Development) Industry Network or PALADIN.

Read more on PALADIN's formation.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

Connected Trial Execution: Why Integrating IRT, eCOA and Clinical Supply Matters More Than Ever

ACT Brief: Payment Performance as Operational Brand, Speed and Discipline in Biotech Development Strategy, and Non-GLP-1 Obesity Candidate Licensing